Peptide stacks · Weight and metabolism · also called Metabolic Reset
Retatrutide and MOTS-c stack: what’s in it and the evidence
Checked against our library and study pagesPublished by PepVault
The Metabolic Reset stack is a blend of two compounds, retatrutide and MOTS-c, that the peptide community runs for fat loss. It isn’t one vial: the amounts the library records per dose are 2 → 4 mg (trial escalation) of retatrutide and 5–10 mg of MOTS-c.
This page describes what the crowd runs and what a vial holds. It recommends no stack and names no seller.
What’s in the Metabolic Reset stack
| Part | Amount | What it’s there for | Evidence (library) |
|---|---|---|---|
| Retatrutide | 2 → 4 mg (trial escalation) | Triple GIP/GLP-1/glucagon agonist — appetite suppression, energy expenditure & glucose control | Established |
| MOTS-c | 5–10 mg | Mitochondrial-derived peptide — AMPK activation and insulin sensitivity in mice | Emerging |
The amount per dose the library records, part by part
Retatrutide
In the Metabolic Reset stack, retatrutide is listed for “Triple GIP/GLP-1/glucagon agonist — appetite suppression, energy expenditure & glucose control”. The first triple agonist to reach phase 3: it activates GLP-1, GIP and glucagon receptors at once, and the glucagon arm adds extra calorie burn (shown in mice).
MOTS-c
In the Metabolic Reset stack, MOTS-c is listed for “Mitochondrial-derived peptide — AMPK activation and insulin sensitivity in mice”. A peptide encoded by the mitochondrial DNA, the energy-producing organelles inside every cell.

Model. Individual results vary.
Has the Metabolic Reset stack been studied as a combination?
None of our 436 study pages tested retatrutide and MOTS-c together, so the Metabolic Reset stack rests on studies of its parts and on community reports.
What the library says about the evidence for the Metabolic Reset stack
No combination-specific published human data exist for retatrutide plus MOTS-c.
The studies of the parts, one by one: 16 study pages on retatrutide (12 in people) and 12 study pages on MOTS-c (1 in people).
| Part | Study pages | In people | Strongest study page |
|---|---|---|---|
| Retatrutide | 16 | 12 | Retatrutide: systolic blood pressure down 6.79 mmHg in meta-analysis (meta-analysis, 2026) |
| MOTS-c | 12 | 1 | MOTS-c rose after 16 weeks of exercise in non-Hispanic White survivors (randomized trial, 2021) |
What people commonly report on the Metabolic Reset stack
Commonly reported: steadier energy through the deficit.
These are reports from people who run it, collected in the library, not results from a trial and not a promise of what any one person will notice.
Why these are combined
The library gives four reasons for combining the parts of the Metabolic Reset stack:
- Retatrutide cuts appetite via triple-receptor signaling while MOTS-c activates AMPK to improve how cells use fuel (mouse data) — top-down plus bottom-up.
- MOTS-c improved insulin sensitivity and glucose uptake in mice; with retatrutide the glucose-lowering effects could add up, which is a monitoring point rather than a proven benefit.
- Retatrutide's glucagon component raises energy expenditure (shown in mice), and MOTS-c supports the mitochondria doing that work; the two haven't been tested together.
- MOTS-c helps preserve lean muscle during the deficit by supporting muscle mitochondria (mouse data); this is untested in people.
From the library’s notes on the Metabolic Reset stack
An increasingly common pairing: retatrutide acts on appetite and incretin signaling, MOTS-c on cellular energy. Both lower glucose, so their effects can add up (see combination safety).
“Retatrutide + MOTS-c attacks metabolism from two angles”, the library’s note on the pair (community report)
Retatrutide works top-down (appetite, gut, satiety via triple-agonism); MOTS-c works bottom-up (mitochondrial efficiency + glucose handling at the cell).
“Tirzepatide + MOTS-c pairs appetite control with cellular burn”, the library’s note on the pair (community report)
Tirzepatide handles the intake side (dual GIP/GLP-1 appetite suppression); MOTS-c supports mitochondrial glucose handling underneath. The combination targets weight from "eat less" + "use it better" rather than doubling down on one lever. As with any GLP-1 stack, protein and resistance training are what protect lean mass while the appetite suppression does its work — the peptides don't replace that.
“Semaglutide + MOTS-c: appetite down, mitochondria supported”, the library’s note on the pair (community report)
Semaglutide is the most-studied GLP-1 for appetite + satiety; MOTS-c adds mitochondrial + metabolic support at the cellular level. The pairing is intake-down plus efficiency-up.
How the parts of the Metabolic Reset stack are mixed and taken
The Metabolic Reset stack isn’t one pre-mixed vial in the library: each part has its own route and schedule, as its entry records them.
| Part | Route | How often | Our vial pages |
|---|---|---|---|
| Retatrutide | SubQ injection | Weekly | 5 mg vial, 10 mg vial, 15 mg vial, 20 mg vial, 24 mg vial, 30 mg vial, 40 mg vial, 60 mg vial |
| MOTS-c | SubQ injection, IM injection | 2–3× weekly | 10 mg vial, 40 mg vial |
Our vial pages work out the mix for each part’s own vial, size by size:
Compared with running the parts apart
The library’s notes on the Metabolic Reset stack don’t compare it with running either part on its own.
Safety notes
The library’s combination safety note on the Metabolic Reset stack
Both act on glucose/metabolic pathways, so the shared, mechanism-plausible consideration is additive glucose-lowering and the need for glucose monitoring — particularly for anyone also using insulin or antidiabetic agents — which is worth raising with a clinician. Retatrutide's individual GI and heart-rate considerations and MOTS-c's preclinical-only safety status both apply.
These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.
Questions people ask
What is in the Metabolic Reset stack?
The Metabolic Reset stack is a blend of two compounds, retatrutide and MOTS-c, that the peptide community runs for fat loss. It isn’t one vial: the amounts the library records per dose are 2 → 4 mg (trial escalation) of retatrutide and 5–10 mg of MOTS-c.
Has the Metabolic Reset stack been studied together?
Not as a combination in any of our study pages: the Metabolic Reset stack rests on studies of its parts and on community reports. From the library: No combination-specific published human data exist for retatrutide plus MOTS-c.
What do people report on the Metabolic Reset stack?
Commonly reported: steadier energy through the deficit. These are reports from people who run it.
Do the parts of the Metabolic Reset stack come in one vial?
No: in the library each part of the Metabolic Reset stack is its own compound with its own route and schedule (retatrutide by SubQ injection and MOTS-c by SubQ injection).
What does each part of the Metabolic Reset stack do?
The library lists retatrutide for “Triple GIP/GLP-1/glucagon agonist — appetite suppression, energy expenditure & glucose control” and MOTS-c for “Mitochondrial-derived peptide — AMPK activation and insulin sensitivity in mice”.
What does the library say about the Metabolic Reset stack’s safety?
No combination-specific published human data exist for retatrutide plus MOTS-c. Both act on glucose/metabolic pathways, so the shared, mechanism-plausible consideration is additive glucose-lowering and the need for glucose monitoring — particularly for anyone also using insulin or antidiabetic agents — which is worth raising with a clinician. These are reference notes from published research and reported use, not advice for a person.